Stocks · Health care · Pharmaceutical Preparations

Lyell Immunopharma, Inc.

LYEL Clue Score29

United States Fiscal year ends December CIK 0001806952 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net buying

Individual transactions

Insider

Date

Role

Action

Price

Amount

ARCH Venture Fund XIII, L.P.

4 Nov 2026

10% owner

Buy indirect

2,321,262

$10.77

$25.00M

ARCH Venture Partners IX, LLC

4 Nov 2026

10% owner

Buy indirect

2,321,262

$10.77

$25.00M

ARCH Venture Fund XIII, L.P.

6 Mar 2026

10% owner

Buy indirect

488,090

$25.61

$12.50M

ARCH Venture Partners IX, LLC

6 Mar 2026

10% owner

Buy indirect

488,090

$25.61

$12.50M

Show all 33 transactions →

What was left out

Form 4 filings counted 47

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 0

Sales at will 27

Transactions with no price 0

Shares from compensation/vesting 261,750

History held since 23 Jun 2021